Implementation of a smoking cessation protocol in dental practices
ISRCTN | ISRCTN19783832 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN19783832 |
Secondary identifying numbers | NTR614 |
- Submission date
- 04/04/2006
- Registration date
- 04/04/2006
- Last edited
- 18/08/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr J.E. Jacobs
Scientific
Scientific
University Medical Center St Radboud
Center for Quality of Care Research (WOK)
P.O. Box 9101
Nijmegen
6500 HB
Netherlands
Phone | +31 (0)24 3615310 |
---|---|
j.jacobs@kwazo.umcn.nl |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Other |
Study type | Treatment |
Scientific title | |
Study acronym | TAPS |
Study objectives | The intervention increases advice given by dental professionals, the number of patients having quit smoking and the number of quit attempts. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Tobacco addiction |
Intervention | Provision of a 4 hour central course for whole practice teams, patient-mediated monitoring and feedback of the provision of cessation advice, patient education materials and a task organisation protocol for the various members of the dental team. The dental teams in the control group deliver usual care. |
Intervention type | Other |
Primary outcome measure | Patient-reported number of smoking cessation advice given by the dental team, patients' smoking status and quit attempts. |
Secondary outcome measures | Professionals' attitudes towards smoking and smoking cessation support, their knowledge of health consequences of smoking tobacco (especially dental health), patients' perspectives of smoking cessation. Support by dentists will be measured as well as self-efficacy to provide smoking cessation support. |
Overall study start date | 01/01/2006 |
Completion date | 01/11/2008 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 1300 |
Key inclusion criteria | Smoking patients visiting dental practices. |
Key exclusion criteria | Patients under the age of 18. |
Date of first enrolment | 01/01/2006 |
Date of final enrolment | 01/11/2008 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
University Medical Center St Radboud
Nijmegen
6500 HB
Netherlands
6500 HB
Netherlands
Sponsor information
University Medical Center St Radboud, Center for Quality of Care Research (WOK) (The Netherlands)
Not defined
Not defined
117 KWAZO
P.O. Box 9101
Nijmegen
6500 HB
Netherlands
https://ror.org/05wg1m734 |
Funders
Funder type
Industry
Pfizer (Netherlands)
Government organisation / For-profit companies (industry)
Government organisation / For-profit companies (industry)
- Alternative name(s)
- Pfizer Inc., Pfizer Consumer Healthcare, Davis, Charles Pfizer & Company, Warner-Lambert, King Pharmaceuticals, Wyeth Pharmaceuticals, Seagen
- Location
- United States of America
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |